<HashMap><database>biostudies-literature</database><scores/><additional><submitter>de Araujo S</submitter><funding>Fundação de Amparo à Pesquisa do Estado de Minas Gerais</funding><funding>Conselho Nacional de Desenvolvimento Científico e Tecnológico</funding><funding>Medical Research Council</funding><funding>L'Oréal-UNESCO-ABC</funding><pagination>2717</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9454528</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(17)</volume><pubmed_abstract>Chikungunya (CHIKV) is an arthritogenic alphavirus that causes a self-limiting disease usually accompanied by joint pain and/or polyarthralgia with disabling characteristics. Immune responses developed during the acute phase of CHIKV infection determine the rate of disease progression and resolution. Annexin A1 (&lt;i>AnxA1&lt;/i>) is involved in both initiating inflammation and preventing over-response, being essential for a balanced end of inflammation. In this study, we investigated the role of the &lt;i>AnxA1-FPR2/ALX&lt;/i> pathway during CHIKV infection. Genetic deletion of &lt;i>AnxA1&lt;/i> or its receptor enhanced inflammatory responses driven by CHIKV. These knockout mice showed increased neutrophil accumulation and augmented tissue damage at the site of infection compared with control mice. Conve</pubmed_abstract><journal>Cells</journal><pubmed_title>Annexin A1-FPR2/ALX Signaling Axis Regulates Acute Inflammation during Chikungunya Virus Infection.</pubmed_title><pmcid>PMC9454528</pmcid><funding_grant_id>MR/No17544/1</funding_grant_id><funding_grant_id>Fapemig Hospedeiro em Dengue Project</funding_grant_id><funding_grant_id>Para Mulheres na Ciência prize</funding_grant_id><funding_grant_id>Instituto Nacional de Ciência e Tecnologia em Dengue</funding_grant_id><pubmed_authors>Souza DG</pubmed_authors><pubmed_authors>Costa VV</pubmed_authors><pubmed_authors>de Araujo S</pubmed_authors><pubmed_authors>Moreira TP</pubmed_authors><pubmed_authors>Goncalves MR</pubmed_authors><pubmed_authors>Bonilha CS</pubmed_authors><pubmed_authors>Nogueira ML</pubmed_authors><pubmed_authors>de Sousa CDF</pubmed_authors><pubmed_authors>Felix FB</pubmed_authors><pubmed_authors>Sugimoto MA</pubmed_authors><pubmed_authors>Campolina-Silva GH</pubmed_authors><pubmed_authors>Teixeira MM</pubmed_authors><pubmed_authors>Perretti M</pubmed_authors><pubmed_authors>de Melo Costa VR</pubmed_authors><pubmed_authors>Santos FM</pubmed_authors><pubmed_authors>Queiroz-Junior CM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Annexin A1-FPR2/ALX Signaling Axis Regulates Acute Inflammation during Chikungunya Virus Infection.</name><description>Chikungunya (CHIKV) is an arthritogenic alphavirus that causes a self-limiting disease usually accompanied by joint pain and/or polyarthralgia with disabling characteristics. Immune responses developed during the acute phase of CHIKV infection determine the rate of disease progression and resolution. Annexin A1 (&lt;i>AnxA1&lt;/i>) is involved in both initiating inflammation and preventing over-response, being essential for a balanced end of inflammation. In this study, we investigated the role of the &lt;i>AnxA1-FPR2/ALX&lt;/i> pathway during CHIKV infection. Genetic deletion of &lt;i>AnxA1&lt;/i> or its receptor enhanced inflammatory responses driven by CHIKV. These knockout mice showed increased neutrophil accumulation and augmented tissue damage at the site of infection compared with control mice. Conve</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-18T15:35:24.025Z</modification><creation>2025-04-07T02:21:02.534Z</creation></dates><accession>S-EPMC9454528</accession><cross_references><pubmed>36078125</pubmed><doi>10.3390/cells11172717</doi></cross_references></HashMap>